Table 2

Effects of 100NA,RO-H on in vivo growth of CAG heparanase-low myeloma cells

Mouse tag no.100NA,RO-H, mg/kg per dTumor wet weight,* mgSerum kappa light chain, ng/mL
502B 400 7424 
3F44 140 2676 
133F 200 2325 
3648 110 1407 
4B1F 130 1432 
611A 100 3461 
1949 18 50 523 
793A 18 30 
C573 18 
353A 18 
7C23 18 
5D4B 18 116 
Mouse tag no.100NA,RO-H, mg/kg per dTumor wet weight,* mgSerum kappa light chain, ng/mL
502B 400 7424 
3F44 140 2676 
133F 200 2325 
3648 110 1407 
4B1F 130 1432 
611A 100 3461 
1949 18 50 523 
793A 18 30 
C573 18 
353A 18 
7C23 18 
5D4B 18 116 
*

Mean tumor weights: No 100NA,RO-H, 180 mg; 18 mg/kg per day group, 40 mg (two tumors only). No 100NA,RO-H group versus 18 mg/kg per day group, P = .003.

Mean kappa levels at termination of treatment: No 100NA,RO-H, 3121 ng; 18 mg/kg per day group, 109 ng; No 100NA,RO-H S group versus 18 mg/kg per day group, P = .004.

or Create an Account

Close Modal
Close Modal